Tag: DISTALS study
Rapid completes enrolment in DISTALS trial evaluating Tigertriever 13 device for...
Rapid Medical has announced the completion of patient enrolment in the DISTALS trial—a multicentre randomised study assessing the Tigertriever 13 device in patients with distal/medium-vessel occlusions...
Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13...
Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions...
Rapid Medical begins enrolment in DISTALS trial treating new ischaemic stroke...
Rapid Medical announced today the enrolment of the first patient in the DISTALS study, which the company claims is the first-ever US Food and...
Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...
